---
title: GeNext Genomics Pvt. Ltd. vs WuXi Vaccines
slug_a: genextgenomics
slug_b: wuxivaccines
site: cdmo
review_signal_gate: closed
canonical_path: /compare/genextgenomics/wuxivaccines
---

# GeNext Genomics Pvt. Ltd. vs WuXi Vaccines

Side-by-side profile data from each company listing on this directory.

## GeNext Genomics Pvt. Ltd.

- Profile: [/companies/genextgenomics](/companies/genextgenomics)

GeNext Genomics Pvt. Ltd. — GeNext Genomics is a central India-based contract research organization offering recombinant protein, antibody, and assay development services. The company also sells research reagents and diagnostic kits.

Services: 8. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Discovery Research
- Protein Engineering
- Immunology & Inflammation Services
- Proteomics Services
- Bioinformatics & Data Science
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)

### Development capabilities

- Cell line development

### Manufacturing capabilities

- Expression: Microbial
- Expression: Mammalian

## WuXi Vaccines

- Profile: [/companies/wuxivaccines](/companies/wuxivaccines)

WuXi Vaccines — Global CDMO specializing in end-to-end vaccine and prophylactic antibody development and manufacturing across mammalian, viral, and microbial platforms with GMP-certified facilities and over 550 million doses delivered.

Services: 11. Modalities: 4. Indications: 1. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Vaccine Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development
- Quality Control Testing

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- mRNA
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial
- Expression: Viral Vector